Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease

Antiochia, Riccarda

doi:10.3390/bios11040110

Cited by 48 publications

(56 citation statements)

References 135 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is also due to the fact that in contrast to other promising paper-based analytical platforms that mainly remain as laboratory prototypes, LFIA devices easily enter into real-life applications with a high market penetration mainly because they do not need extensive upgrades to become an end-user device [ 18 ]. The wide acceptance of LFIA devices also played an eminent role in the use of the platform for the detection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the current pandemic situation, as we can still notice and as extensively reported in the literature [ 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 ].…”

Section: Introductionmentioning

confidence: 99%

Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives

Nardo

Chiarello

Cavalera

et al. 2021

Sensors

234

162

View full text Add to dashboard Cite

The Lateral Flow Immunoassay (LFIA) is by far one of the most successful analytical platforms to perform the on-site detection of target substances. LFIA can be considered as a sort of lab-in-a-hand and, together with other point-of-need tests, has represented a paradigm shift from sample-to-lab to lab-to-sample aiming to improve decision making and turnaround time. The features of LFIAs made them a very attractive tool in clinical diagnostic where they can improve patient care by enabling more prompt diagnosis and treatment decisions. The rapidity, simplicity, relative cost-effectiveness, and the possibility to be used by nonskilled personnel contributed to the wide acceptance of LFIAs. As a consequence, from the detection of molecules, organisms, and (bio)markers for clinical purposes, the LFIA application has been rapidly extended to other fields, including food and feed safety, veterinary medicine, environmental control, and many others. This review aims to provide readers with a 10-years overview of applications, outlining the trends for the main application fields and the relative compounded annual growth rates. Moreover, future perspectives and challenges are discussed.

show abstract

Section: Introductionmentioning

confidence: 99%

Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives

Nardo

Chiarello

Cavalera

et al. 2021

Sensors

234

162

View full text Add to dashboard Cite

show abstract

“… Disclaimer: the cost analysis approximates the cost for the materials and reagents required to make one testing device based on a mix of reported material costs and independent research into the materials used [ 12 , 98 , 99 , 100 ]. …”

Section: Figurementioning

confidence: 99%

“…Comparison of several recent advancements in SARS-CoV-2 detection methods and their future on-site diagnostic potential for SARS-CoV-2. : the cost analysis approximates the cost for the materials and reagents required to make one testing device based on a mix of reported material costs and independent research into the materials used[12,[98][99][100].…”

mentioning

confidence: 99%

Integrated Microfluidic-Based Platforms for On-Site Detection and Quantification of Infectious Pathogens: Towards On-Site Medical Translation of SARS-CoV-2 Diagnostic Platforms

Escobar

Chiu

et al. 2021

Micromachines

View full text Add to dashboard Cite

The rapid detection and quantification of infectious pathogens is an essential component to the control of potentially lethal outbreaks among human populations worldwide. Several of these highly infectious pathogens, such as Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been cemented in human history as causing epidemics or pandemics due to their lethality and contagiousness. SARS-CoV-2 is an example of these highly infectious pathogens that have recently become one of the leading causes of globally reported deaths, creating one of the worst economic downturns and health crises in the last century. As a result, the necessity for highly accurate and increasingly rapid on-site diagnostic platforms for highly infectious pathogens, such as SARS-CoV-2, has grown dramatically over the last two years. Current conventional non-microfluidic diagnostic techniques have limitations in their effectiveness as on-site devices due to their large turnaround times, operational costs and the need for laboratory equipment. In this review, we first present criteria, both novel and previously determined, as a foundation for the development of effective and viable on-site microfluidic diagnostic platforms for several notable pathogens, including SARS-CoV-2. This list of criteria includes standards that were set out by the WHO, as well as our own “seven pillars” for effective microfluidic integration. We then evaluate the use of microfluidic integration to improve upon currently, and previously, existing platforms for the detection of infectious pathogens. Finally, we discuss a stage-wise means to translate our findings into a fundamental framework towards the development of more effective on-site SARS-CoV-2 microfluidic-integrated platforms that may facilitate future pandemic diagnostic and research endeavors. Through microfluidic integration, many limitations in currently existing infectious pathogen diagnostic platforms can be eliminated or improved upon.

show abstract

“…The fabrication of microchannels or patterns on the substrates of lab-on-paper devices is mainly performed by filling the holes in the paper base with hydrophobic materials to form microchannels and impermeable barriers, or by cutting. The patterning process can be performed using many different methods, including laser printing, inkjet printing, plotting, wax printing, process cutting, flexographic printing, wet etching, laser cutting, screen printing, photolithography, chemical vapor deposition, knife drawing, spray coating, plasma treatment, sol-gel, handheld corona treatment, imprinting, 3D printing, embossing, and so on [21][22][23][24][25][26][27][28]. Each method has its own specific merits and drawbacks.…”

Section: Introductionmentioning

confidence: 99%

Lab-on-Paper Devices for Diagnosis of Human Diseases Using Urine Samples—A Review

et al. 2021

View full text Add to dashboard Cite

In recent years, microfluidic lab-on-paper devices have emerged as a rapid and low-cost alternative to traditional laboratory tests. Additionally, they were widely considered as a promising solution for point-of-care testing (POCT) at home or regions that lack medical infrastructure and resources. This review describes important advances in microfluidic lab-on-paper diagnostics for human health monitoring and disease diagnosis over the past five years. The review commenced by explaining the choice of paper, fabrication methods, and detection techniques to realize microfluidic lab-on-paper devices. Then, the sample pretreatment procedure used to improve the detection performance of lab-on-paper devices was introduced. Furthermore, an in-depth review of lab-on-paper devices for disease measurement based on an analysis of urine samples was presented. The review concludes with the potential challenges that the future development of commercial microfluidic lab-on-paper platforms for human disease detection would face.

show abstract

Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease

Cited by 48 publications

References 135 publications

Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives

Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives

Integrated Microfluidic-Based Platforms for On-Site Detection and Quantification of Infectious Pathogens: Towards On-Site Medical Translation of SARS-CoV-2 Diagnostic Platforms

Lab-on-Paper Devices for Diagnosis of Human Diseases Using Urine Samples—A Review

Contact Info

Product

Resources

About